Biofrontera
BFRI
11 hedge funds and large institutions have $1.67M invested in Biofrontera in 2024 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 3 closing their positions.
6,136% more capital invested
Capital invested by funds: $26.7K → $1.67M (+$1.64M)
100% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 3
38% more funds holding
Funds holding: 8 → 11 (+3)
20.7% more ownership
Funds ownership: 0.64% → 21.33% (+21%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RA
Rosalind Advisors
Toronto,
Ontario, Canada
|
+$699K |
| 2 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$695K |
| 3 |
SC
Scotia Capital
Toronto,
Ontario, Canada
|
+$55.5K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$16.9K |
| 5 |
HF
HRT Financial
New York
|
+$14.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$2.29K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.76K |
| 3 |
Morgan Stanley
New York
|
-$1.11K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$46 |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$30 |
BFRI Hedge Fund Activity: Q1 2024 in Review
11 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Biofrontera (BFRI) for Q1 2024, worth a combined $1.67M — up 6,136% from $26.7K a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new BFRI positions and 3 closed out — a net gain of 3 holders — while 0 added to existing stakes and 2 trimmed.
The largest buyer was Rosalind Advisors, opening a new position worth an estimated $699K. The largest seller was JP Morgan Chase, exiting entirely with an estimated $2.29K sold.
- 11 institutional investors held Biofrontera (BFRI) as of Q1 2024, up from 8 in Q4 2023.
- Funds reported $1.67M of Biofrontera stock for Q1 2024, up 6,136% quarter-over-quarter.
- 6 funds opened new Biofrontera positions in Q1 2024 and 3 closed out, a net change of +3 holders.
- The largest Biofrontera buyer in Q1 2024 was Rosalind Advisors, an estimated $699K added.
- The largest Biofrontera seller in Q1 2024 was JP Morgan Chase, an estimated $2.29K sold.
Based on aggregated 13F filings for Q1 2024.